RevitalVision

Join us on August 15 for the #VSPVisionInnovationChallenge! We are extremely excited and honored to be one of the five finalists participating and presenting our groundbreaking technology to industry leaders at this event. RSVP here: https://lnkd.in/e2VPH-RK #healthcare #entrepreneurs #innovation #eycareprofessionals #digitalhealth #VSPVisionInnovationChallenge MATTER VSP Global Innovation Center Yair Yahav Charles Morris

We are excited to announce that we are one of the five finalists globally selected to participate in the VSP Vision Innovation Challenge! The VSP Vision Innovation Challenge, hosted by MATTER, is a prestigious competition designed to identify and support cutting-edge startups and innovators in the vision care industry. This challenge aims to discover solutions that can significantly enhance eye care delivery and improve the overall patient experience. As part of this challenge, we will have the opportunity to collaborate with industry leaders and showcase our groundbreaking vision improvement solution to a global audience. Thank you VSP Vision and MATTER for this incredible opportuinity. Visit the MATTER blog to learn more about the finalists and the showcase taking place on August 15 ➡️ https://bit.ly/4eWw3f7 Stay tuned for more exciting developments! #eyecare #ophthalmology #visioncare #medicaldevices #VisionInnovation #eyecareprofessionals

Thank you ISRAEL21C for this enlightening article about #RevitalVision home based vision training program. The article beautifully illustrates how our simple home-based brain training technology greatly enhances vision and quality of life for our patients Read the full article https://lnkd.in/d3BjwK3s ##braintraining #innovativetechnology ##medicaldevice #digitalhealth #visionimprovement

We are thrilled to announce that Prof. Yair Morad will be presenting RevitalVision at the ESA-ISA 2024 Joint Meeting of the European and International Strabismological Associations, taking place in Toulouse France 13-15 June.  This event brings together the leading minds in pediatric ophthalmology, strabismus, orthoptic, and binocular vision, to share knowledge, exchange ideas, and explore the latest developments in these areas. Professor Yair Morad will speak about Adult Amblyopia Treatment, sharing the latest clinical trial results with #RevitalVision. RevitalVision offers an effective solution to improve vision in amblyopia beyond the critical age, when occlusion therapy is no longer effective. It is the only FDA cleared and CE -Marked product for older children and adults with amblyopia.  The presentation will take place on: June 13, 2024 , 11:35-12:35 We look forward to seeing you at ESA-ISA 2024 and hope you will join us for this enlightening session. #ESAISA2024 #Strabismology #Ophthalmology #AdultAmblyopia #VisionCare #EyeHealth #InnovativeTreatment #MedicalResearch #amblyopia

In this article featured on BW HEALTHCARE WORLD ; "Using Brain Science to Improve Low Vision in 2024," Dr. Monica Samant discusses innovative approaches that leverage neuroplasticity to improve visual capabilities, providing new hope for low vision patients. This approach represents a shift from traditional optical corrections, focusing instead on the brain's role in visual perception. A standout technology in this field is RevitalVision, which uses clinically proven visual training programs to stimulate the visual cortex, resulting in vision improvementn for conditions such as amblyopia, eye diseases, and other visual impairments. A special thanks to the author Dr. Monica Samant for shedding light on this groundbreaking work. This not only broadens our understanding of vision science but also brings practical benefits to those affected by low vision. Read the full article: https://lnkd.in/dYEi8Vqc Here are some relevant hashtags to use on LinkedIn for this post: #BrainScience #LowVision #VisionHealth #Neuroplasticity #VisualImpairment #VisionImprovement #HealthcareInnovation #Neuroscience #RevitalVision #EyeCare #MedicalTechnology #HealthTech #VisionTherapy #PatientCare

Eye care professionals? Hear from top industry leaders about improving vision in Amblyopia- beyond the critical age Join us on Thursday for a Doctors' webinar on Improving Vision in Amblyopia! Learn how leading experts Dr. Geetha Srinivasan and Dr. Digvijay Singh used RevitalVision software to improve patients' vision and quality of life. Register here: https://lnkd.in/d-B5Az5b #amblyopia #eyecareprofessionals #india #opthalmology #lowvision

👁️Exclusive webinar for Eye Care Professionals!👁️ 🔍Learn how leading experts Dr. Geetha Srinivasan and Dr. Digvijay Singh used RevitalVision software to improve patients' vision and quality of life. 🗓️Save the date: 16th May, 5-6 pm (India Standard Time) Secure your spot today and gain valuable Insights! Register here: https://lnkd.in/d-B5Az5b #amblyopia #eyecareprofessionals #india #opthalmology #eyecare

Improving Vision in Congenital Nystagmus - Pivotal RCT Results - presented at AAPOS 20024 We are happy to share the groundbreaking findings from a prospective randomized controlled trial evaluating RevitalVision's efficacy in improving vision in Congenital Nystagmus patients. The study demonstrated statistically significant improvement in distance and near BCVA, as well as substantial improvement in binocular and stereo vision, giving hope to nystagmus patients who are lacking alternative solutions. Watch the recorded presentation of Dr. Idan Hecht from last week's AAPOS annual meeting. RevitalVision offers an effective tool to improve vision in nystagmus and amblyopic patients age 9 or older, with a prescribed, home-based cortical-stimulation software program. For more information go to https://lnkd.in/dsM6aUxe or contact us at info@revitalvision.com #nystagmus #aapos #lowvision #opthalmology #pediatricopthalmology

Cortical stimulation software improves vision in nystagmus & keratoconus RevitalVision announced the success of two prospective randomized controlled trials evaluating the efficacy of its technology in congenital Nystagmus and stable Keratoconus patients post-CXL. Both studies demonstrated significant vision improvement outcomes. Offering hope to millions lacking effective treatments, RevitalVision is the only FDA-cleared product for amblyopia in children over 9 and adults when occlusion therapy is no longer effective. Clinically proven to enhance vision across various vision impairments and eye diseases by targeting the brain.

We had a great start to the 2024 American Association for Pediatric Ophthalmology and Strabismus Conference (#AAPOS). Stop by booth T37 to meet our team and learn about our cortical stimulation technology that improves the brain's visual processing and see how you can easily integrate it into your clinic. Don't miss the live presentation about RevitalVision's groundbraking RCT Results in Patients with Congenital Nystagmus. The presentation will take place on Wednesday, April 10th, from 12:32 p.m. to 12:39 p.m. Hope to see you all there! #eyedoctor   #visioncare  #digitalhealth  #aapos2024  #ophthalmology #pediatricophthalmology